Evidence map›Paper›PMID 39630398›Full record

Observational studyJournal of endocrinological investigation2025

Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem.

Tommaso Piticchio, S Wolde Sellasie, F D'Arrigo, F Galeano, I Barca, A Prinzi, R Le Moli, L Scappaticcio, S Amendola, L Guidobaldi and 5 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of endocrinological investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tommaso PiticchioEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy. tommaso.piticchio@phd.unict.it.ORCID http://orcid.org/0000-0002-0567-6494
S Wolde SellasieDivision of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
F D'ArrigoEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
F GaleanoEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
I BarcaEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
A PrinziEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
R Le MoliEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.
L ScappaticcioUnit of Endocrinology and Metabolic Diseases, AOU University of Campania "Luigi Vanvitelli", Naples, Italy.
S AmendolaDivision of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
L GuidobaldiUOC of Pathologic Anatomy and Cytodiagnostic, Sandro Pertini Hospital, Rome, ASL RM2, 00157, RM, Italy.
I NardoneDivision of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
S ZaccariaDivision of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
F PallottiDepartment of Medicine and Surgery, University Kore of Enna, Enna, Italy.
L UccioliDivision of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, Rome, Italy.
Frasca FEndocrinology Section, Department of Clinical and Experimental Medicine, Garibaldi Nesima Hospital, University of Catania, Catania, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThyroid nodules diagnosed by fine needle aspiration cytology (FNAC) as TIR3A or Class III subgroup "other types of atypia" (indeterminate thyroid nodules - ITNs), are the only ones without a unique clinical action indicated for management. This leads to multiple FNAC repetitions (FNAC-reps) and lifelong follow-up, with huge consumption of time and resources. The aims of the study were to inquire the usefulness of repeating FNAC in ITNs and perform an evaluation of a long-term follow-up of a large cohort of ITNs.

methodsThe study was conducted in two Italian high-volume tertiary centres. We selected patients who underwent the first FNAC with subsequent diagnosis of ITN in a centre involved and who then repeated it in the same institute.

resultsWe included 506 patients. The FNAC-rep determined the "change in management indications" (CMIs) in 30 cases. The binomial test showed that this proportion was not significant (p 0.36). The factors related to CMIs were age (OR = 0.97; 95%CI = 0.95-0.99; p = 0.04), margins (OR = 5.6; 95%CI = 1.7-18.1; p = 0.004), and echogenicity (hypoechoic vs. isoechoic: OR = 5.2; 95%CI = 1.87-14.5; p = 0.002| hypoechoic vs. iso-anechoic: OR = 5.9; 95%CI = 1.32-26.2; p = 0.02). Follow-up of cases without CMIs showed that 20 of 476 cases required surgery. Of these, only four were malignant and all occurred within the first 8 years of observation.

conclusionsThe study demonstrated that FNAC-rep is useless for the most of cases, hence it should only be considered for young adults having nodules with suspicious characteristics. Furthermore, a 10-year follow-up for ITNs is safe enough rather than a long-life follow-up.

Indexed as

Precision MedicineThyroid NeoplasmsThyroid NoduleAdultAgedBiopsy, Fine-NeedleDisease ManagementFemaleFollow-Up StudiesHumansItalyMaleMiddle AgedPrognosisRetrospective StudiesAUSFollow-upIndeterminate noduleMalignancyThyroid noduleTIR3A

Identifiers

PMID39630398
PMCPMC11950127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.